EquityFlow › Companies › Orbis Medicines

Orbis Medicines

Biotech · Copenhagen, DK

Oral macrocycle drug discovery platform

Funding history

DateRoundAmount
Mar 2024Seed
Copenhagen biotech Orbis Medicines raised EUR 26M in seed financing led by Novo Holdings and Forbion for oral macrocycle drug discovery.
$28.1M

Investors

ForbionNovo Holdings

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →